These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists. Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE. Bioorg Med Chem Lett; 2000 Oct 16; 10(20):2247-50. PubMed ID: 11055330 [Abstract] [Full Text] [Related]
23. In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro. Sánchez C, Arnt J, Didriksen M, Dragsted N, Moltzen Lenz S, Matz J. Psychopharmacology (Berl); 1998 Jun 16; 137(3):233-40. PubMed ID: 9683000 [Abstract] [Full Text] [Related]
24. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity. Hirose H, Aoki I, Kimura T, Fujikawa T, Numazawa T, Sasaki K, Sato A, Hasegawa T, Nishikibe M, Mitsuya M, Ohtake N, Mase T, Noguchi K. J Pharmacol Exp Ther; 2001 May 16; 297(2):790-7. PubMed ID: 11303071 [Abstract] [Full Text] [Related]
25. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats. Munns M, Pennefather JN. Br J Pharmacol; 1998 Apr 16; 123(8):1639-44. PubMed ID: 9605571 [Abstract] [Full Text] [Related]
27. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists. Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G. J Med Chem; 2003 Feb 27; 46(5):856-67. PubMed ID: 12593665 [Abstract] [Full Text] [Related]
28. Nicotine administration decreases the number of binding sites and mRNA of M1 and M2 muscarinic receptors in specific brain regions of rat neonates. Zhu J, Taniguchi T, Konishi Y, Mayumi M, Muramatsu I. Life Sci; 1998 Feb 27; 62(12):1089-98. PubMed ID: 9519811 [Abstract] [Full Text] [Related]
29. J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors. Mitsuya M, Mase T, Tsuchiya Y, Kawakami K, Hattori H, Kobayashi K, Ogino Y, Fujikawa T, Satoh A, Kimura T, Noguchi K, Ohtake N, Tomimoto K. Bioorg Med Chem; 1999 Nov 27; 7(11):2555-67. PubMed ID: 10632066 [Abstract] [Full Text] [Related]
30. Sulfide analogues as potent and selective M(2) muscarinic receptor antagonists. Wang Y, Chackalamannil S, Hu Z, McKittrick BA, Greenlee W, Ruperto V, Duffy RA, Lachowicz JE. Bioorg Med Chem Lett; 2002 Apr 08; 12(7):1087-91. PubMed ID: 11909724 [Abstract] [Full Text] [Related]
31. Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes. Rinken A. J Pharmacol Exp Ther; 1995 Jan 08; 272(1):8-14. PubMed ID: 7815368 [Abstract] [Full Text] [Related]
32. Muscarinic M3 receptor inactivation reveals a pertussis toxin-sensitive contractile response in the guinea pig colon: evidence for M2/M3 receptor interactions. Sawyer GW, Ehlert FJ. J Pharmacol Exp Ther; 1999 Apr 08; 289(1):464-76. PubMed ID: 10087039 [Abstract] [Full Text] [Related]
33. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens. Shannon HE, Sawyer BD, Bemis KG, Bymaster FP, Health I, Mitch CH, Ward JS. Eur J Pharmacol; 1993 Feb 23; 232(1):47-57. PubMed ID: 8458395 [Abstract] [Full Text] [Related]
34. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells. Stephan CC, Sastry BV. Cell Mol Biol (Noisy-le-grand); 1992 Nov 23; 38(7):701-12. PubMed ID: 1282058 [Abstract] [Full Text] [Related]
35. Involvement of the M2 muscarinic receptor in contractions of the guinea pig trachea, guinea pig esophagus, and rat fundus. Thomas EA, Ehlert FJ. Biochem Pharmacol; 1996 Mar 22; 51(6):779-88. PubMed ID: 8602873 [Abstract] [Full Text] [Related]
36. The design and pharmacology of novel selective muscarinic agonists and antagonists. Lambrecht G, Gross J, Hacksell U, Hermanni U, Hildebrandt C, Hou X, Moser U, Nilsson BM, Pfaff O, Waelbroeck M. Life Sci; 1995 Mar 22; 56(11-12):815-22. PubMed ID: 10188780 [Abstract] [Full Text] [Related]
37. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis. Wess J, Bonner TI, Brann MR. Mol Pharmacol; 1990 Dec 22; 38(6):872-7. PubMed ID: 2174507 [Abstract] [Full Text] [Related]
38. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine. Roffel AF, Davids JH, Elzinga CR, Wolf D, Zaagsma J, Kilbinger H. Br J Pharmacol; 1997 Sep 22; 122(1):133-41. PubMed ID: 9298539 [Abstract] [Full Text] [Related]
39. Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Lachowicz JE, Duffy RA, Ruperto V, Kozlowski J, Zhou G, Clader J, Billard W, Binch H, Crosby G, Cohen-Williams M, Strader CD, Coffin V. Life Sci; 2001 Apr 27; 68(22-23):2585-92. PubMed ID: 11392630 [Abstract] [Full Text] [Related]
40. Characterization of muscarinic receptors mediating vasodilation in guinea-pig ileum submucosal arterioles by the use of computer-assisted videomicroscopy. Bungardt E, Vockert E, Feifel R, Moser U, Tacke R, Mutschler E, Lambrecht G, Surprenant A. Eur J Pharmacol; 1992 Mar 17; 213(1):53-61. PubMed ID: 1499657 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]